CME Group Inc.
As of Oct 23, 2026 close
- Market cap
- $110.45B
- P/E (TTM)
- 25.85
- Forward P/E
- 22.75
- Dividend yield
- 1.68%
- 52-week range
- $218.31$329.16
- Volume (live)
- -
- Avg. volume (3M)
- 2.01M
CME Group (CME) Stock Price & Financial Analysis
CME Group Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $303.93 - $307.78 |
|---|---|
| 52-Week High | $329.16 |
| 52-Week Low | $218.31 |
| Open | $305.06 |
| Volume (last close) | 2.18M |
| Average Volume (3M) | 2.01M |
| Revenue (TTM) | 6.77B |
|---|---|
| Net Income (TTM) | 4.27B |
| Free Cash Flow (TTM) | 4.21B |
| EPS (TTM) | $11.82 |
| Profit Margin | 63.12% |
| Operating Margin | 65.14% |
| Return on Equity (ROE) | 16.11% |
| Debt to Equity | 0.13 |
| Annual Dividend | $5.15 |
|---|---|
| Dividend Yield | 1.68% |
| Payout Ratio | 43.55% |
| Last Dividend Ex-Date | Sep 9, 2026 |
| Market Cap | 110.45B |
|---|---|
| Shares Outstanding | 361.28M |
| P/E Ratio (TTM) | 25.85 |
| Forward P/E | 22.75 |
| Price to Sales (P/S) | 16.32 |
| Price to Book (P/B) | 4.16 |
| EV/EBITDA | 19.54 |
| 50-Day MA | $275.00 |
|---|---|
| 200-Day MA | $278.92 |
| 1-Year Change | +13.79% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
CME Group at a Glance
As of the Oct 23, 2026 close, CME Group (CME) has a market capitalization of $110.45B. The stock trades at 25.9× trailing earnings, 22.8× forward earnings and 16.3× sales. Over the trailing twelve months it earned $4.27B on revenue of $6.77B (a 63.1% profit margin) and generated $4.21B of free cash flow. Revenue grew 5.1% year over year.
As of its latest reported balance sheet, it holds $2.14B in cash and securities against $3.42B of debt, a net debt position of $1.28B.
CME Group pays a quarterly dividend totaling $5.15 per share a year, a 1.68% yield at the Oct 23, 2026 close, with a 44% payout ratio and 15 consecutive years of dividend increases.
The share price is up 13.8% over the past year. At $305.71 (the Oct 23, 2026 close) it sits within its 52-week range of $218.31 to $329.16, above its 200-day moving average of $278.92.
Based on 16 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $307.92, 0.7% above the Oct 23, 2026 close.
Frequently Asked Questions About CME Group
What is the current stock price for CME?
As of the Oct 23, 2026 close, CME stock trades at $305.71. The 52-week range is $218.31–$329.16, with a day range of $303.93–$307.78.
What is the P/E ratio for CME?
As of the Oct 23, 2026 close, CME Group's trailing twelve-month (TTM) P/E ratio is 25.9, meaning investors pay $25.9 for every $1 of annual earnings. The forward P/E is 22.8, reflecting analyst expectations for future earnings. CME Group operates in the Financials sector.
Does CME pay dividends?
Yes, CME Group pays a 1.68% annual dividend yield as of the Oct 23, 2026 close ($5.15 per share a year). The trailing twelve-month payout ratio is 43.5%. The most recent ex-dividend date was September 9, 2026.
What do analysts recommend for CME?
Based on ratings from 16 professional analysts over the last 90 days, the consensus for CME is Buy. The average 12-month price target is $307.92, a 0.7% upside from the Oct 23, 2026 close of $305.71.
What is the market cap of CME?
As of the Oct 23, 2026 close, CME Group's market capitalization is $110.45B, classifying it as a large-cap company. CME Group operates in the Financials sector within the Financial Data & Stock Exchanges industry.